🇺🇸 FILGRASTIM in United States

18,380 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 3,618 reports (19.68%)
  2. Neutropenia — 2,500 reports (13.6%)
  3. Off Label Use — 2,164 reports (11.77%)
  4. Pyrexia — 1,965 reports (10.69%)
  5. Diarrhoea — 1,571 reports (8.55%)
  6. Thrombocytopenia — 1,436 reports (7.81%)
  7. Pneumonia — 1,323 reports (7.2%)
  8. Nausea — 1,310 reports (7.13%)
  9. Death — 1,261 reports (6.86%)
  10. Anaemia — 1,232 reports (6.7%)

Source database →

FILGRASTIM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is FILGRASTIM approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for FILGRASTIM in United States?

Marketing authorisation holder not available in our data.